Verona Pharma

VRNA | NASDAQ | 0 Obserwujący

$84.34

-1.40%

-$1.20

Obserwuj

Overview Metrics Financials

Fair Price

$79.50

Overvalued by 61.3%

Aby wyświetlić sprawiedliwą cenę akcji, musisz być członkiem Bulios Black.

Company Quality

Profitability Score

17/100

Solvency Score

70/100

Dividends

Dividends data currently unavailable.

Earnings

8/14/2025

in 66 days

Revenue est.

-0.02

EPS est.

My Notes

You haven't added any notes for this stock yet. Use this space to record your insights or strategies.

Profile

Healthcare

Sektor

Biotechnology

Branża

Dr. David S. Zaccardelli Pharm.D.

Prezes

209

Pracownicy

London

Siedziba główna

Kraj

Verona Pharma is a UK-based biotechnology company specializing in the development of drugs targeting respiratory diseases, particularly chronic lung diseases such as chronic obstructive pulmonary disease (COPD) and asthma. The company is focused on developing innovative therapeutic options aimed at improving lung function and reducing inflammation in the airways. Verona Pharma concentrates on researching and developing medicines that can improve the quality of life for patients suffering from these chronic respiratory conditions.

Verona Pharma

Fair Price

Company Quality

Dividends

Earnings

My Notes

Profile

Key Metrics TTM

Performance

Earnings Waterfall

Debt level and coverage

Earnings

Feed

Zaloguj się do Bulios

Utwórz profil Bulios

Dlaczego Bulios?